This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent. Top assignees: Fujirebio Diagnostics, Inc., Pacific Northwest Diabetes Research Institute. Active years: 2017.
Company Filing History:
1 out of 1 
1 out of 1 Years Active: 2017
Title: The Innovations of John Raycraft
Introduction
John Raycraft is an accomplished inventor based in Clayton, CA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to ovarian cancer. His innovative work has led to the development of a patent that addresses critical aspects of cancer assessment.
Latest Patents
John Raycraft holds a patent for "Compositions and methods of use for determination of HE4a." This invention utilizes HE/HE4a markers to assess ovarian cancer in subjects. The patent includes compositions and methods for diagnosing, grading, and staging ovarian cancers, as well as determining prognosis and treatment effectiveness for individuals diagnosed with this disease. He has 1 patent to his name.
Career Highlights
Throughout his career, John has worked with notable organizations, including the Pacific Northwest Diabetes Research Institute and Fujirebio Diagnostics, Inc. His experience in these institutions has allowed him to refine his expertise in medical research and diagnostics.
Collaborations
John has collaborated with esteemed colleagues such as Christian Fermér and Ingegerd E Hellstrom. These partnerships have contributed to the advancement of his research and the successful development of his patent.
Conclusion
John Raycraft's innovative contributions to ovarian cancer diagnostics highlight his dedication to improving medical outcomes. His work exemplifies the impact of research and invention in the field of healthcare.